PARP inhibitor and CX-5461 combination therapy as a novel treatment strategy for castrate-resistant prostate cancer

Laura H Porter, Mitchell G Lawrence, Nicholas K Choo, Shahneen Sandhu, Hong Wang, David Pook, Elaine Sanij, Richard B Pearson, Ross Hannan, Luc Furic, Renea A Taylor, Gail P Risbridger